Agenda
-
2:00 PM-4:00 PM EST In-Person Meeting Room
Pre-Conference: Early Career Committee Workshops - Non-CME
-
-
5:30 PM-6:00 PM EST In-Person Ballroom
Challenges in implementing methylation in screening and diagnostics
-
9:00 AM-9:10 AM EST In-Person Ballroom
Acknowledgement to Country and Introduction by the Farrah Fawcett Foundation
-
9:10 AM-9:40 AM EST In-Person Ballroom
Farrah Fawcett Foundation Keynote Address: Update on the ACT Study
Speakers:
Dr Duncan Charles Gilbert, MRCP FRCR PhD
Consultant Clinical Oncologist and Associate Professor in Cancer and Clinical TrialsUniversity Hospitals Sussex NHS Foundation Trust, and University College London
-
10:00 AM-10:15 AM EST In-Person Ballroom
Update on the expanding role of chemotherapy in the treatment of anal cancer
-
10:20 AM-10:40 AM EST In-Person Ballroom
Oncology Updates - What we're preventing - Selected Oral Abstract Presentations - Non-CME
-
11:25 AM-11:40 AM EST In-Person Ballroom
The role of pelvic physiotherapy in the management of anal cancer
-
12:10 PM-12:30 PM EST In-Person Ballroom
Optimising the patient experience - a team approach - Selected Oral Abstract Presentations - Non-CME
-
1:55 PM-2:20 PM EST In-Person Ballroom
Biomarkers to improve efficiency and coverage of anal cancer prevention programs
-
2:20 PM-3:00 PM EST In-Person Ballroom
Update on Epidemiology - Selected Oral Abstract Presentations - Non-CME
-
3:30 PM-4:00 PM EST In-Person Ballroom
Successes and challenges that might influence the roll out of anal screening programs
Speakers:
Professor Karen Veronica Canfell AC, D.Phil
Professor of Public Health & NHMRC Leadership Fellow; Lead - Cancer Elimination Collaboration; Lead - Elimination Partnership In Cervical Cancer (EPICC)Cancer Elimination Collaboration (CEC), Sydney School of Public Health, University of Sydney
-
4:20 PM-5:00 PM EST In-Person Ballroom
Screening Options - Selected Oral Abstract Presentations - Non-CME
-
9:00 AM-10:20 AM EST In-Person Ballroom
Acknowledgment to Country & Different Perspectives on Screening Panel
Panelist:
- Mary Poynten, MBBS, MPH, PHD, Senior Research Fellow, Kirby Institute, UNSW Sydney
- David Chromy, MD PhD, Medical University of Vienna
- Dr. Carlos Manuel Angeles San Mateo, MD, MA, FACS, DABS, DipABLM, FASCRS, Colorectal Surgeon, Alkimiya Surgical Systems, PC
-
12:00 PM-1:00 PM EST In-Person Ballroom
Screening & guidelines high-risk groups - Selected Oral Abstract Presentations - Non-CME
-
2:00 PM-2:20 PM EST In-Person Ballroom
Standardising Clinical Trial Design - definitions, AE collection, cure vs. clearance
-
Speakers:
Dr Duncan Charles Gilbert, MRCP FRCR PhD
Consultant Clinical Oncologist and Associate Professor in Cancer and Clinical TrialsUniversity Hospitals Sussex NHS Foundation Trust, and University College London
-
3:45 PM-5:00 PM EST In-Person Ballroom
Implementation - Selected Oral Abstract Presentations - Non-CME
-
9:00 AM-9:30 AM EST In-Person Ballroom
Acknowledgement to Country & Updates on pathogenesis and the prospect of therapeutic vaccines
-
Panelist:
- Tamzin Cuming, MD, IANS President, IANS
- David Chromy, MD PhD, Medical University of Vienna
-
11:40 AM-11:55 AM EST In-Person Ballroom
The role of HPV DNA in determining follow-up of anal dysplasia
-
11:55 AM-12:30 PM EST In-Person Ballroom
Treatments, screening diagnostics, and AI - Selected Oral Abstract Presentations - Non-CME
-
1:30 PM-2:30 PM EST In-Person Ballroom
Panel - Learning from patient experience - using patients' perspectives to shape expectations and guide future research - Non-CME
-
-
3:15 PM-3:30 PM EST
Women without other known risk factors
-
3:30 PM-3:45 PM EST In-Person Ballroom
Canada's first dedicated cancer clinic for trans and non-binary individuals
